Extension without change of a currently approved collection
No
Regular
08/31/2023
Requested
Previously Approved
36 Months From Approved
09/30/2023
60,000
60,000
30,000
30,000
0
0
Through this ICR FDA will obtain data
on safety information to support quick-turnaround decision-making
about potential safety problems or risk management solutions. This
information will be collected from health professionals, hospitals,
and other user facilities (e.g., nursing homes, ambulatory surgical
facilities and outpatient diagnostic and treatment facilities,
etc.), consumers, sponsors and manufacturers of biologics, drugs
and medical products, distributors, and importers when FDA must
quickly determine whether or not a problem with a medical product
impacts the public health.
We have adjusted the total
burden hours that results in a decrease of 50,000 responses and
25,000 total hours. This reduction in burden is a result of fewer
rapid response surveys being conducted.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.